Chronic Kidney Disease Progression Risk in Patients With Diabetes Mellitus Using Dihydropyridine Calcium Channel Blockers: A Nationwide, Population-Based, Propensity Score Matching Cohort Study

Background: Whether diabetes mellitus (DM) patients with chronic kidney disease (CKD) can glean individual renal benefit from dihydropyridine calcium channel blockers (DCCBs) remains to be determined. We conducted a nationwide, population-based, propensity score matching cohort study to examine the...

Descripción completa

Detalles Bibliográficos
Autores principales: Lin, Shih-Yi, Lin, Cheng-Li, Lin, Cheng-Chieh, Hsu, Wu-Huei, Hsu, Chung-Y., Kao, Chia-Hung
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Frontiers Media S.A. 2022
Materias:
Pharmacology
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8959929/
https://www.ncbi.nlm.nih.gov/pubmed/35355728
http://dx.doi.org/10.3389/fphar.2022.786203

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8959929/
https://www.ncbi.nlm.nih.gov/pubmed/35355728
http://dx.doi.org/10.3389/fphar.2022.786203

Ejemplares similares